Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease.

Key Findings:  This study supports the hypothesis that the endocannabinoid system plays an important role in the development and expression of dyskinesias and might be an effective target for the treatment of L-DOPA-induced dyskinesias.

Type of Study:  Animal Study

Study Result:  Positive

Cannabinoids Studied:  Other Related Compounds

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable

Receptors Studied:  TRPV1, PPAR - Alpha

Study Location(s):  Spain

Year of Pub:  2014

Link to study